📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate (2024)

First Author: Brown A

Attributed to: COVID-19 Longitudinal Health and Wellbeing - National Core Study (LWH-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.16062

PubMed Identifier: 38589944

Publication URI: http://europepmc.org/abstract/MED/38589944

Type: Journal Article/Review

Parent Publication: British Journal of Clinical Pharmacology

ISSN: 0306-5251